Evan Lockwood Rachlin bought IAM once, on Oct 16, 2026
Director at Iambic Therapeutics, Inc.
SEC CIK 0002151678 · Filings on SEC.gov ↗
$11.5MBought
$0Sold
Oct 19Last buy
Evan Lockwood Rachlin's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
1 filing since Oct 2026, newest first
Filings come from SEC EDGAR. Not investment advice.